Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-4-27
pubmed:abstractText
Initiation of productive immune responses against Leishmania depends on the successful transition of dendritic cells (DC) from an immature to a mature phenotype. This process is characterized by high CD40 surface expression as well as interleukin-12 production, which are frequently seen in response to L. major infection. In vivo footpad infection of C3HeB/FeJ mice for 7 days with L. amazonensis promoted an immature CD11c(+) DC phenotype characterized by both significantly low CD40 surface expression and significantly decreased interleukin-12p40 production compared with L. major infection of these same mice. In vitro infection of bone marrow-derived dendritic cells with L. amazonensis amastigotes resulted in rapid and significant phosphorylation of the mitogen activated protein kinase, extracellular signal-regulated kinase 1/2, observed within minutes of exposure to the parasite. Infection with L. amazonensis promastigotes led to increased 1/2 phosphorylation after 4 hours of infection compared with L. major infection, which correlated with promastigote transformation into amastigotes. Treatment of bone marrow-derived dendritic cells with a mitogen activated protein kinase kinase-specific inhibitor, PD98059, led to regained surface CD40 expression and interleukin-12p40 production following L. amazonensis amastigote infection compared with non-treated, infected DC. Treatment of L. amazonensis-infected mice with the highly-specific mitogen activated protein kinase kinase inhibitor, CI-1040, enhanced surface CD40 expression on CD11c(+) DC obtained from the draining lymph node. L. amazonensis amastigotes, through activation of extracellular signal-regulated kinase 1/2, inhibit the ability of DC to undergo proper maturation both in vitro and in vivo.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-10037236, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-10586030, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-10861073, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-11242034, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-11895981, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-12164286, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-12706437, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-15573115, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-15831826, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-16212907, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-16267021, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-16352421, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-16495525, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-16818784, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-17543969, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-17682041, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-18538399, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-7612219, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-8624816, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-8624817, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-8624818, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-8766560, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-9509670, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-9521319, http://linkedlifedata.com/resource/pubmed/commentcorrection/19349356-9841930
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1525-2191
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
174
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1818-26
pubmed:dateRevised
2010-9-24
pubmed:meshHeading
pubmed-meshheading:19349356-Animals, pubmed-meshheading:19349356-Antigens, CD11c, pubmed-meshheading:19349356-Antigens, CD40, pubmed-meshheading:19349356-Bone Marrow, pubmed-meshheading:19349356-Dendritic Cells, pubmed-meshheading:19349356-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:19349356-Female, pubmed-meshheading:19349356-Flow Cytometry, pubmed-meshheading:19349356-Fluorescent Antibody Technique, Indirect, pubmed-meshheading:19349356-Host-Parasite Interactions, pubmed-meshheading:19349356-Immunoblotting, pubmed-meshheading:19349356-Leishmania, pubmed-meshheading:19349356-Mice, pubmed-meshheading:19349356-Mice, Inbred C3H, pubmed-meshheading:19349356-Mice, SCID, pubmed-meshheading:19349356-Mitogen-Activated Protein Kinase 1, pubmed-meshheading:19349356-Mitogen-Activated Protein Kinase 3, pubmed-meshheading:19349356-Mitogen-Activated Protein Kinases, pubmed-meshheading:19349356-Phenotype, pubmed-meshheading:19349356-Phosphorylation
pubmed:year
2009
pubmed:articleTitle
Altered dendritic cell phenotype in response to Leishmania amazonensis amastigote infection is mediated by MAP kinase, ERK.
pubmed:affiliation
Department of Veterinary Pathology, Iowa State University, Ames, Iowa 50011, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural